logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Advances In The Treatment Of Kidney And Upper Urinary Tract Cancers 1st Edition Lukasz Zapala

  • SKU: BELL-56459030
Advances In The Treatment Of Kidney And Upper Urinary Tract Cancers 1st Edition Lukasz Zapala
$ 31.00 $ 45.00 (-31%)

4.4

22 reviews

Advances In The Treatment Of Kidney And Upper Urinary Tract Cancers 1st Edition Lukasz Zapala instant download after payment.

Publisher: MDPI
File Extension: PDF
File size: 18.5 MB
Pages: 174
Author: Lukasz Zapala, Pawel Rajwa
ISBN: 9783725805532, 3725805539
Language: English
Year: 2024
Edition: 1

Product desciption

Advances In The Treatment Of Kidney And Upper Urinary Tract Cancers 1st Edition Lukasz Zapala by Lukasz Zapala, Pawel Rajwa 9783725805532, 3725805539 instant download after payment.

Kidney and Upper Tract Urinary Cancers (UTUCs) are diseases of increasing population coverage, the treatment of which is undergoing a continuous process of evolution. A characteristic feature of renal cell cancer (RCC) treatment is the significant heterogeneity of patients (including different stages of local advancement and different locations of metastases). Importantly, it is estimated that up to 30% of newly diagnosed RCC cases are patients with disseminated disease at the time of diagnosis. Therefore, predicting the response to modern treatment remains the unmet need of modern urologic oncology. Recent advancements in systematic treatment, i.e., immunotherapy, shed additional light on adjuvant treatment to be implemented in new clinical scenarios, including localized disease.

Related Products